Skip to main content
. 2022 Feb 24;13:805986. doi: 10.3389/fphar.2022.805986

TABLE 6.

Screening of mitragynine (1) and speciociliatine (3) at opioid receptor (Obeng et al., 2020).

Binding site Percent displacement of bound radioligand
Mitragynine (1) Speciociliatine (3)
100 nM 10,000 nM 100 nM 10,000 nM
MOR 29.0 93.7 64.7 98.0
KOR 25.2 88.3 61.9 98.5
DOR 0.4 18.3 0.6 69.2
Nociceptin/Orphanin FQ peptide (NOP) 4.3 40.8 −14.9 31.8